SAAVY (270-701) Site 4+
Medable, Inc.
Designed for iPad
-
- Free
iPad Screenshots
Description
This app is specifically intended for study participants in the BioMarin Pharmaceuticals Inc. (270-701) Seroprevalence and Seroconversion Study
App Privacy
The developer, Medable, Inc., has not provided details about its privacy practices and handling of data to Apple. For more information, see the developer’s privacy policy.
No Details Provided
The developer will be required to provide privacy details when they submit their next app update.
Information
- Provider
- Medable, Inc.
- Size
- 92.9 MB
- Category
- Health & Fitness
- Compatibility
-
- iPad
- Requires iPadOS 13.0 or later.
- Mac
- Requires macOS 11.0 or later and a Mac with Apple M1 chip or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English, Bulgarian, Czech, Danish, Dutch, French, German, Hungarian, Italian, Japanese, Korean, Polish, Russian, Simplified Chinese, Spanish, Swedish, Traditional Chinese, Turkish, Ukrainian
- Age Rating
- 4+
- Copyright
- © Medable, Inc.
- Price
- Free